Results 41 to 50 of about 986 (111)

Exploring Polypharmacy in the BC Correctional Health Setting. [PDF]

Can J Hosp Pharm
Lo L, Masson S, Brons M, Leung B.
europepmc   +1 more source

Effect of oliceridine on hypoxia during sedated hysteroscopy: a Phase 4 randomized clinical trial. [PDF]

Commun Med (Lond)
Liu Y, Tao M, Dai B, Yin X, Gu X, Xiao J, Cao JL, Yu W, Yang L, Zhang S.   +9 more
europepmc   +1 more source

The Over-the-Counter Medicines Market in Poland. [PDF]

Int J Environ Res Public Health, 2022
Lasota D, Mirowska-Guzel D, Goniewicz M.
europepmc   +1 more source

Intraoperative Local Anesthesia and Opioid Use in Enhanced Recovery After Surgery-based Breast Reduction. [PDF]

Plast Reconstr Surg Glob Open
Sajdlowska J, Garcia AM, Sartorato F, Buckley A, Callahan M, Shen Y, Podda S, Palu-Regan JP.   +7 more
europepmc   +1 more source

"With a little help from my friends" - collaborating with community experts to improve sampling and obtain a high response rate for a statewide naloxone availability survey. [PDF]

BMC Public Health
Shubel C, Marley G, Isac A, Bell R, Fagan B, Bordeaux M, Carpenter D, Ostrach B.   +7 more
europepmc   +1 more source

Challenges in opioid therapy implementation: national survey of palliative care consultation services. [PDF]

BMC Palliat Care
Mueller E, Gahr S, Schnell A, Schildmann E, Boehlke C, Roch C.   +5 more
europepmc   +1 more source

A Comprehensive HPLC-HRMS/MS Targeted Screening Method to Detect 90 New Psychoactive Substances in Oral Fluid Samples. [PDF]

Biology (Basel)
Spinella I, Altieri F, Pichini S, Minutillo A, Di Trana A.   +4 more
europepmc   +1 more source

Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder^® as a Real-Time Predictive Tool. [PDF]

Pharmaceuticals (Basel)
Deligianni E, Arillotta D, Vento A, Corkery JM, Papazisis G, Goulas A, Lione L, Schifano F.   +7 more
europepmc   +1 more source

Naltrexone dose-selectively modulates goal-directed behavior and the hypothalamic proteome in rats. [PDF]

Pharmacol Rep
Malikowska-Racia N, Mielczarek P, Popik P.   +2 more
europepmc   +1 more source

Door-to-door overdose harm reduction: an Illinois case study. [PDF]

Harm Reduct J
Mason M, Johnson B, Schaffner C, Johnston S, Alexander U, Ajala O, Andrews N, Welch SB.   +7 more
europepmc   +1 more source